CVS Health: Back In The Buy Column

Bloomberg/Bloomberg via Getty Images This article was co-produced with Chuck Walston. Although I characterize myself as a largely buy-and-hold investor, I'll admit I kicked CVS Health Corporation (NYSE:CVS) stock to the curb when the company froze its dividend. I did this even though I understood the logic behind management's decision. Back in 2017, CVS made a bold move to acquire Aetna, a health insurance company, for $77 billion, including debt assumption. That acquisition caused CVS's leverage ratios to ...